EP2841456 - HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.04.2019 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 11.05.2018 | ||
Former | Grant of patent is intended Status updated on 20.12.2017 | ||
Former | Examination is in progress Status updated on 03.03.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1799 / US | [2018/24] |
Former [2015/10] | For all designated states Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | ||
For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1799 / US | Inventor(s) | 01 /
ANDERSEN, Mette, Dahl c/o Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | 02 /
DANTZLER, Jeff 14012 Wayne Pl. N. Seattle, WA 98133 / US | 03 /
ARMITAGE, Richard, J. 5840 Packard Lane Bainbridge Island, WA 98110 / US | 04 /
CLARK, Rutilio 5335 Old Mill Road NE Bainbridge Island, WA 98110 / US | [2015/10] | Representative(s) | EIP Fairfax House 15 Fulwood Place London WC1V 6HU / GB | [N/P] |
Former [2018/24] | EIP EIP Europe LLP Fairfax House 15 Fulwood Place London WC1V 6HU / GB | ||
Former [2015/10] | Petersen, Birgit Otzen, et al Novo Nordisk A/S Corporate Patents Novo Allé 2880 Bagsværd / DK | Application number, filing date | 13720714.8 | 25.04.2013 | [2018/24] | WO2013US38135 | Priority number, date | US201261639637P | 27.04.2012 Original published format: US 201261639637 P | [2015/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013163377 | Date: | 31.10.2013 | Language: | EN | [2013/44] | Type: | A1 Application with search report | No.: | EP2841456 | Date: | 04.03.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.10.2013 takes the place of the publication of the European patent application. | [2015/10] | Type: | B1 Patent specification | No.: | EP2841456 | Date: | 13.06.2018 | Language: | EN | [2018/24] | Search report(s) | International search report - published on: | EP | 31.10.2013 | Classification | IPC: | C07K16/28 | [2015/10] | CPC: |
C07K16/2875 (EP,IL,RU,US);
A61K39/3955 (RU);
C07K16/28 (KR);
A61K39/395 (KR);
A61P13/12 (EP,IL);
A61P17/00 (EP,IL);
A61P19/02 (EP,IL);
A61P19/06 (EP,IL);
A61P21/00 (EP,IL);
A61P25/00 (EP,IL);
A61P27/02 (EP,IL);
A61P29/00 (EP,IL);
A61P3/04 (EP,IL);
A61P3/10 (EP,IL);
A61P35/00 (EP,IL);
A61P35/02 (EP,IL);
A61P37/00 (EP,IL);
A61P37/02 (EP,IL);
A61P37/06 (EP,IL);
A61P43/00 (EP,IL);
A61P5/16 (EP,IL);
A61P5/38 (EP,IL);
C07K14/70575 (EP,IL,US);
C07K16/2803 (KR);
A61K2039/505 (EP,IL,US);
C07K2317/21 (EP,IL,US);
C07K2317/34 (EP,IL,US);
C07K2317/55 (EP,IL,US);
C07K2317/565 (IL,US);
C07K2317/732 (EP,IL,US);
C07K2317/76 (EP,IL,US);
C07K2317/92 (EP,IL,US);
C07K2319/21 (EP,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/10] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | HUMANE CD30 LIGAND ANTIGEN BINDENDE PROTEINE | [2018/02] | English: | HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS | [2015/10] | French: | PROTÉINES DE LIAISON AU LIGAND DE CD30 HUMAINE | [2018/02] |
Former [2015/10] | MENSCHLICHES CD30-LIGANDANTIGEN BINDENDE PROTEINE | ||
Former [2015/10] | PROTÉINES DE LIAISON À L'ANTIGÈNE LIGAND CD30 HUMAIN | Entry into regional phase | 27.11.2014 | National basic fee paid | 27.11.2014 | Designation fee(s) paid | 27.11.2014 | Examination fee paid | Examination procedure | 27.11.2014 | Examination requested [2015/10] | 18.06.2015 | Amendment by applicant (claims and/or description) | 10.03.2017 | Despatch of a communication from the examining division (Time limit: M06) | 20.09.2017 | Reply to a communication from the examining division | 04.10.2017 | Despatch of a communication from the examining division (Time limit: M02) | 30.11.2017 | Reply to a communication from the examining division | 21.12.2017 | Communication of intention to grant the patent | 27.04.2018 | Receipt of the translation of the claim(s) | 30.04.2018 | Fee for grant paid | 30.04.2018 | Fee for publishing/printing paid | Divisional application(s) | EP18169942.2 / EP3431492 | EP20207117.1 / EP3929208 | EP22188601.3 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.03.2017 | Opposition(s) | 14.03.2019 | No opposition filed within time limit [2019/21] | Fees paid | Renewal fee | 30.04.2015 | Renewal fee patent year 03 | 02.05.2016 | Renewal fee patent year 04 | 02.05.2017 | Renewal fee patent year 05 | 27.04.2018 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 13.06.2018 | CY | 13.06.2018 | EE | 13.06.2018 | HR | 13.06.2018 | LT | 13.06.2018 | LV | 13.06.2018 | MC | 13.06.2018 | MK | 13.06.2018 | MT | 13.06.2018 | RS | 13.06.2018 | SM | 13.06.2018 | IS | 13.10.2018 | [2022/31] |
Former [2021/34] | AL | 13.06.2018 | |
CY | 13.06.2018 | ||
EE | 13.06.2018 | ||
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
MC | 13.06.2018 | ||
MT | 13.06.2018 | ||
RS | 13.06.2018 | ||
SM | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2020/02] | AL | 13.06.2018 | |
CY | 13.06.2018 | ||
EE | 13.06.2018 | ||
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
MC | 13.06.2018 | ||
RS | 13.06.2018 | ||
SM | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2019/51] | AL | 13.06.2018 | |
CY | 13.06.2018 | ||
EE | 13.06.2018 | ||
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
RS | 13.06.2018 | ||
SM | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2019/12] | CY | 13.06.2018 | |
EE | 13.06.2018 | ||
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
RS | 13.06.2018 | ||
SM | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2019/09] | CY | 13.06.2018 | |
EE | 13.06.2018 | ||
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
RS | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2019/08] | CY | 13.06.2018 | |
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
RS | 13.06.2018 | ||
IS | 13.10.2018 | ||
Former [2018/51] | CY | 13.06.2018 | |
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
LV | 13.06.2018 | ||
RS | 13.06.2018 | ||
Former [2018/50] | CY | 13.06.2018 | |
HR | 13.06.2018 | ||
LT | 13.06.2018 | ||
Former [2018/47] | LT | 13.06.2018 | Cited in | International search | [A]WO9324135 (IMMUNEX CORP [US]); | [I]WO0211767 (IMMUNEX CORP [US], et al); | by applicant | US4399216 | WO8705330 | WO8801649 | US4740461 | US4751180 | US4816567 | US4912040 | WO9004036 | EP0367566 | US4935233 | US4946778 | US4959455 | US4965195 | US4968607 | US5011912 | WO9110741 | EP0460846 | WO9203918 | WO9222646 | WO9301227 | WO9310151 | EP0546073 | US5260203 | US5262522 | WO9402602 | WO9410308 | US5426048 | US5457035 | US5480981 | US5530101 | US5545807 | US5545806 | US5569825 | WO9633735 | US5585089 | US5625126 | US5633425 | US5661016 | EP0546073 | US5677430 | US5693762 | US5693761 | WO9824893 | US5770429 | US5789650 | US5814318 | US5874299 | US5877397 | WO9910494 | WO0009560 | US6143869 | US6162963 | US6180370 | US6255458 | US6270964 | US6300129 | US6652854 | US6667039 | US6673986 | US6713610 | US6946292 | US7425446 | US7846725 | US8067232 |